financetom
Business
financetom
/
Business
/
CoreWeave Stock Is Tumbling Wednesday: What's Fueling The Sell-Off?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CoreWeave Stock Is Tumbling Wednesday: What's Fueling The Sell-Off?
Aug 13, 2025 6:24 AM

CoreWeave Inc ( CRWV ) shares are moving lower Wednesday on the heels of the company’s second-quarter financial results. A wider-than-expected loss appears to be weighing on shares.

What To Know: CoreWeave ( CRWV ) reported mixed results for the second-quarter with revenue of $1.21 billion coming in ahead of estimates of $1.08 billion, and a quarterly loss of 27 cents per share versus estimates for a loss of 17 cents per share.

Total revenue was up more than 300% year-over-year. The company, which provides access to Nvidia GPUs to large technology and AI-focused companies, ended the quarter with a revenue backlog of $30.1 billion and $1.15 billion in cash and cash equivalents.

"Our strong second quarter performance demonstrates continued momentum across every dimension of our business,” said Michael Intrator, co-founder and CEO of CoreWeave ( CRWV ).

CoreWeave ( CRWV ) made its public debut on the Nasdaq at $40 per share earlier this year. The stock has more than tripled from those levels, which likely elevated expectations coming into earnings.

On a conference call following the print, CoreWeave ( CRWV ) guided for third-quarter revenue of $1.26 billion to $1.3 billion and full-year revenue of $5.15 billion to $5.35 billion. Analysts were looking for third-quarter revenue of $1.25 billion and full-year revenue of $5.04 billion, according to estimates from Benzinga Pro.

Following the company’s quarterly results, Needham reiterated a Hold and HC Wainwright & Co. maintained a Neutral rating. Stifel also maintained CoreWeave ( CRWV ) with a Hold rating and raised its price target from $115 to $120, suggesting shares may be fully valued following a strong run in recent months.

CRWV Price Action: CoreWeave shares were down 9.91% at $134 at the time of publication Wednesday, according to Benzinga Pro.

Shares are trading within the 52-week range of $33.51 to $187.00. The stock is below its 50-day moving average of $140.78, indicating a bearish trend in the short term. Key support levels may be found near the 100-day and 200-day moving averages at $103.08, which could act as a safety net if selling pressure continues.

Read Next:

From Double-Entry To Deep Learning: The Transformation Of Accounting In The AI Age

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Whitestone REIT Receives Unsolicited, Non-Binding Acquisition Proposal
Whitestone REIT Receives Unsolicited, Non-Binding Acquisition Proposal
Nov 4, 2025
HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Whitestone REIT ( WSR ) , a neighborhood-focused owner and operator of open-air shopping centers in Texas and Arizona, today announced that it has received an unsolicited, non-binding proposal from MCB Real Estate to acquire all of the outstanding shares of the Company’s common stock for cash consideration of $15.20 per share. MCB...
Cadre Holdings Reports Third Quarter 2025 Financial Results
Cadre Holdings Reports Third Quarter 2025 Financial Results
Nov 4, 2025
Grew Quarterly Net Sales 42% and Gross Profit 66% Year-Over-Year Increased Quarterly Adjusted EBITDA of $29.8 Million and Expanded Adjusted EBITDA Margin of 19.1% Organic Backlog Increased $20 Million from Q2 to Q3 Med-Eng Awarded $50 Million IDIQ with DoD – First PO issued for $10 Million to be Shipped in 2026 Agrees to Acquire TYR Tactical, Leading Provider...
Amgen Q3 Adjusted Earnings, Revenue Increase; 2025 Guidance Raised
Amgen Q3 Adjusted Earnings, Revenue Increase; 2025 Guidance Raised
Nov 4, 2025
04:14 PM EST, 11/04/2025 (MT Newswires) -- Amgen ( AMGN ) reported Q3 non-GAAP net income late Tuesday of $5.64 per diluted share, up from $5.58 a year earlier Analysts polled by FactSet expected $5.02. Revenue for the quarter ended Sept. 30 was $9.56 billion, up from $8.50 billion a year earlier. Analysts expected $8.97 billion. For fiscal 2025, the...
Astera Labs Q3 Non-GAAP Earnings, Revenue Rise; Q4 Guidance Issued; Shares Rise After Hours
Astera Labs Q3 Non-GAAP Earnings, Revenue Rise; Q4 Guidance Issued; Shares Rise After Hours
Nov 4, 2025
04:15 PM EST, 11/04/2025 (MT Newswires) -- Astera Labs ( ALAB ) reported Q3 non-GAAP net income late Tuesday of $0.49 per diluted share, up from 0.23 a year earlier. Analysts polled by FactSet expected $0.39. Revenue for the quarter ended Sept. 30 was $230.6 million, up from $113.1 million a year earlier. Analysts surveyed by FactSet expected $206.5 million....
Copyright 2023-2026 - www.financetom.com All Rights Reserved